Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

1.

Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.

Ho CM, Wu CY, Lee PH, Lai HS, Ho MC, Wu YM, Hu RH.

Ann Surg Oncol. 2013 Aug;20(8):2526-33. doi: 10.1245/s10434-013-2940-7. Epub 2013 Mar 16.

PMID:
23504121
[PubMed - indexed for MEDLINE]
2.

Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.

Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.

Transplant Proc. 2012 Mar;44(2):516-9. doi: 10.1016/j.transproceed.2012.01.032.

PMID:
22410059
[PubMed - indexed for MEDLINE]
3.

Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.

Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.

Transplant Proc. 2011 Dec;43(10):3813-8. doi: 10.1016/j.transproceed.2011.09.043.

PMID:
22172852
[PubMed - indexed for MEDLINE]
4.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

PMID:
22672818
[PubMed - indexed for MEDLINE]
Free Article
5.

Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.

Choi HJ, Kim DG, Na GH, Han JH, Hong TH, You YK.

World J Gastroenterol. 2013 Aug 7;19(29):4737-44. doi: 10.3748/wjg.v19.i29.4737.

PMID:
23922471
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.

Piardi T, Gheza F, Ellero B, Woehl-Jaegle ML, Ntourakis D, Cantu M, Marzano E, Audet M, Wolf P, Pessaux P.

Ann Surg Oncol. 2012 Jun;19(6):2020-6. doi: 10.1245/s10434-011-2170-9. Epub 2011 Dec 17.

PMID:
22179632
[PubMed - indexed for MEDLINE]
7.

Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.

Lee KW, Yi NJ, Suh KS.

Transplantation. 2014 Apr 27;97 Suppl 8:S20-3. doi: 10.1097/01.tp.0000446269.20934.d3.

PMID:
24849825
[PubMed - indexed for MEDLINE]
8.

Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.

Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, Francoz C, Compagnon P, Vanlemmens C, Dumortier J, Dharancy S, Gugenheim J, Bernard PH, Adam R, Radenne S, Muscari F, Conti F, Hardwigsen J, Pageaux GP, Chazouillères O, Salame E, Hilleret MN, Lebray P, Abergel A, Debette-Gratien M, Kluger MD, Mallat A, Azoulay D, Cherqui D; Liver Transplantation French Study Group.

Gastroenterology. 2012 Oct;143(4):986-94.e3; quiz e14-5. doi: 10.1053/j.gastro.2012.05.052. Epub 2012 Jun 29.

PMID:
22750200
[PubMed - indexed for MEDLINE]
9.

Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.

Marubashi S, Dono K, Nagano H, Sugita Y, Asaoka T, Hama N, Miyamoto A, Takeda Y, Umeshita K, Monden M.

Transpl Int. 2007 Jul;20(7):576-82. Epub 2007 Apr 8.

PMID:
17425725
[PubMed - indexed for MEDLINE]
10.

A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.

Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Kim IH, Yi NJ, Lee KU.

Surgery. 2007 May;141(5):598-609. Epub 2007 Mar 23.

PMID:
17462459
[PubMed - indexed for MEDLINE]
11.

Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?

Hsieh CB, Chen TW, Chu CM, Chu HC, Yu CP, Chung KP.

World J Gastroenterol. 2010 Jun 28;16(24):3049-55.

PMID:
20572309
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.

Minagawa M, Makuuchi M, Takayama T, Kokudo N.

Ann Surg. 2003 Nov;238(5):703-10.

PMID:
14578733
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.

Green TJ, Rochon PJ, Chang S, Ray CE Jr, Winston H, Ruef R, Kreidler SM, Glueck DH, Shulman BC, Brown AC, Durham J.

J Vasc Interv Radiol. 2013 Nov;24(11):1613-22. doi: 10.1016/j.jvir.2013.07.024. Epub 2013 Sep 20.

PMID:
24060436
[PubMed - indexed for MEDLINE]
14.

Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.

Eguchi S, Takatsuki M, Hidaka M, Soyama A, Tomonaga T, Muraoka I, Kanematsu T.

World J Surg. 2010 May;34(5):1034-8. doi: 10.1007/s00268-010-0424-5.

PMID:
20127241
[PubMed - indexed for MEDLINE]
15.

Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.

Zhang XF, Yin ZF, Wang K, Zhang ZQ, Qian HH, Shi LH.

Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):618-23.

PMID:
23232633
[PubMed - indexed for MEDLINE]
Free Article
16.

Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.

Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Tahara M, Kakisaka T, Tsuruga Y, Todo S, Taketomi A.

World J Surg Oncol. 2012 Jun 14;10:107. doi: 10.1186/1477-7819-10-107.

PMID:
22697061
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The postresection alpha-fetoprotein in cirrhotic patients with hepatocellular carcinoma. An independent predictor of outcome.

Allard MA, Sa Cunha A, Ruiz A, Vibert E, Sebagh M, Castaing D, Adam R.

J Gastrointest Surg. 2014 Apr;18(4):701-8. doi: 10.1007/s11605-013-2433-9. Epub 2014 Jan 9.

PMID:
24402605
[PubMed - indexed for MEDLINE]
18.

Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS.

World J Gastroenterol. 2002 Apr;8(2):237-42.

PMID:
11925599
[PubMed - indexed for MEDLINE]
Free Article
19.
20.

The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.

Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Yi NJ, Lee KU.

Liver Transpl. 2006 Nov;12(11):1655-60. Erratum in: Liver Transpl. 2007 Jan;13(1):175.

PMID:
16964589
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk